glp-1 receptor agonists mechanism of action The Impact on Ocular Disease GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Diabetes, Obes Metab
El-Jamal N, Erdual E, Neunlist M, Koriche D, Dubuquoy C, Maggiotto F, et al
Much of this has been due to further clinical results that showed stronger weight loss efficacy for Zepbound
GLP-1 receptor agonists and DPP4-inhibitor direct the T2DM therapies
The review also noted that decreased GLP-1 secretion may contribute to obesity development, and that exaggerated secretion may be responsible for postprandial reactive hypoglycaemia
